Crystal structure and solid-state properties of 3,4-diaminopyridine dihydrogen phosphate and their comparison with other diaminopyridine salts
Visualitza/Obre
cg3014249.pdf (441,3Kb) (Accés restringit)
Sol·licita una còpia a l'autor
Què és aquest botó?
Aquest botó permet demanar una còpia d'un document restringit a l'autor. Es mostra quan:
- Disposem del correu electrònic de l'autor
- El document té una mida inferior a 20 Mb
- Es tracta d'un document d'accés restringit per decisió de l'autor o d'un document d'accés restringit per política de l'editorial
Cita com:
hdl:2117/18803
Tipus de documentArticle
Data publicació2013-02
Condicions d'accésAccés restringit per política de l'editorial
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement-NoComercial-SenseObraDerivada 3.0 Espanya
Abstract
3,4-Diaminopyridine is an active pharmaceutical ingredient for the treatment of Lambert−Eaton myasthenic
syndrome (LEMS). It is 3,4-diaminopyridine dihydrogen phosphate that has become the active ingredient of choice. As part of a
larger study for the development of this drug, solid-state studies have been carried out. At room temperature, the crystals are
monoclinic (C2/c). Dihydrogen phosphate anions H2PO4
− form infinite chains parallel to the b axis, and these chains can be
considered as macroanions (H2PO4)∞. The organic cations form hydrogen bonds with the macroanions bridging them together.
A negative thermal expansion is observed along the [103] direction in the crystal, which coincides with the direction of chains of
interchanging anions and cations. The crystal packing shows similarities with the hydrogen tartrate salt as illustrated by a
Hirshfeld surface analysis. This phosphate and this tartrate salt are also the two diaminopyridine salts that have been selected for
therapeutic use because of their appropriate physical properties.
CitacióMahe, N. [et al.]. Crystal structure and solid-state properties of 3,4-diaminopyridine dihydrogen phosphate and their comparison with other diaminopyridine salts. "Crystal growth and design", Febrer 2013, vol. 13, núm. 2, p. 708-715.
ISSN1528-7483
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
cg3014249.pdf | 441,3Kb | Accés restringit |